Disclosure pursuant to Regulation 30 read with Schedule III and Regulation 51 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ('Listing Regulations') Amalgamation of the Target Company with the Company pursuant to a scheme of amalgamation under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 (Act) (Scheme). Disclosure under Regulation 30 - Outcome of the Board meeting. Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure requirements) Regulations, 2015 in relation to Scheme of Amalgamation. (As per BSE announcement dated on :24.03.2026). Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 in relation to Scheme of Amalgamation. (As per BSE announcement dated on :25.03.2026) Pronouncement of final order by the Hon''ble National Company Law Tribunal, Ahmedabad Bench sanctioning the Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited with Torrent Pharmaceuticals Limited and their respective shareholders . (As Per BSE Announcement Dated on 06.07.2026) Record date in the matter of Scheme of Amalgamation of J.B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited and their respective shareholders (As Per BSE Announcement Dated on: 07/07/2026) Intimation of Effective Date of Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited and their respective shareholders. Receipt of Certified copy of Order passed by National Company Law Tribunal, Ahmedabad Bench (NCLT) regarding the Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited and their respective shareholders. (As per BSE Announcement dated on: 08.07.2026) Trading members of the Exchange are hereby informed that, pursuant to the Scheme of Amalgamation as approved by the Honble National Company Law Tribunal (NCLT), AHMEDABAD Bench, inter alia, providing for the Amalgamation of J.B. Chemicals & Pharmaceuticals Lt (Transferor Company) INTO Torrent Pharmaceuticals Limited(Transferee Company), J.B. Chemicals & Pharmaceuticals Lt has informed the Record Date fixed for the purpose of Amalgamation and to determine the entitlement of shareholders of J.B. Chemicals & Pharmaceuticals Ltd to the Equity Shares of Torrent Pharmaceuticals Limited as per details given below:- COMPANY NAME & CODE J.B. Chemicals & Pharmaceuticals Ltd (506943/106943) RECORD DATE 17.07.2026 PURPOSE As per Scheme of Amalgamation as approved by the Honble National Company Law Tribunal, New Ahmedabad Bench; Upon coming into effect of the Scheme of Amalgamation and in consideration of the Amalgamation of J.B. Chemicals & Pharmaceuticals Ltd INTO Torrent Pharmaceuticals Limited; Torrent Pharmaceuticals Limited shall Issue and allot Equity Shares to the Shareholders of J.B. Chemicals & Pharmaceuticals Ltd in the following proportion: 51 Fully Paid-up Equity Shares of Torrent Pharmaceuticals Limited having face value of Rs. 5/- each for every 100 Fully Paid-up Equity Shares of Re.1/- each held in J.B. Chemicals & Pharmaceuticals Ltd. No Dealings/ Suspension w.e.f. Date/Settlement No. 17/07/2026 DR-674/2026-2027 Trading Members of the Exchange are requested to take note of it. (As Per BSE Notice Dated on 13.07.2026) Trading Members are requested to refer to Exchange notice number 20260713-39 & 20260713-9 regarding Amalgamation of JB Chemicals & Pharmaceuticals Ltd.(Scrip Code: 506943). In view of the above, Trading Members are requested to note following security shall be excluded from SLB segment with effective Ex-Date 17 th July 2026. Security Name JB Chemicals & Pharmaceuticals Ltd SLB Code JBCHEPHARM Equity Scrip Code 506943 Members are requested to note that there shall be no contracts available for trading in the abovementioned security. (As Per BSE Notice Dated on 16.07.2026)